AURA BIOSCIENCES, INC.
Last · NASDAQ$6.17-0.10 (-1.59%)close · yahoo · 13h ago
Market cap$639.86M103.7M sh
P/E · TTM-3.6fwd -3.0 · eps -1.72 · loss
Beta0.41vs S&P 500
Div yield0.00%annual · TTM
52w range
$4.73$9.535
Volume1.0Msession
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-30
- Operating Cf Burn
- Cash Runway Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.7 years
- Accumulated Deficit High — Accumulated deficit / equity 351%
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.37
Est. revenue
0
Earnings transcripts
Press & signals
- GlobeNewswire
Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- GlobeNewswire
Aura Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
- GlobeNewswire
Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors